- Abstract Number: 2492
ANCA Associated Tracheobronchial Disease
- Abstract Number: 2690
ANCA IgG Promotion of Neutrophil Recruitment, Migration and Vascular Damage in ANCA Associated Vasculitis May Be Enhanced by Hypoxia
- Abstract Number: 0735
ANCA-associated Vasculitis (AAV) and Long-term Risk of Cardiovascular Disease: Large-scale Propensity-matched Global Retrospective Cohort Study
- Abstract Number: 1272
Angiopoietin-2 and Soluble Tumor Necrosis Factor Receptor Type II Are Elevated in Treatment Naïve JDM Plasma and Associate with Increased Muscle Disease Activity and Decreased Nailfold Capillary Density
- Abstract Number: 2424
Anifrolumab Effects on Response to Influenza Vaccine in SLE
- Abstract Number: 1548
Anifrolumab in Systemic Lupus Erythematosus. Spanish National Registry in a Real-world Setting
- Abstract Number: 1776
Animal Models of Pediatric MOGAD
- Abstract Number: 1056
Annual Cost of Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
- Abstract Number: 0035
Anti-CCP Generation in the Female Genital Tract Is Increased During the Postpartum Period in Women Without RA
- Abstract Number: 2427
Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Induces Multicompartmental B Cell Depletion in Peripheral Blood, Bone Marrow and Lymph Nodes of Systemic Lupus Erythematosus
- Abstract Number: 0773
Anti-Citrullinated Histone Antibody CIT-013 Targets NETs in Inflamed Joints and Halts NET-mediated Joint Deterioration
- Abstract Number: 0064
Anti-Citrullinated Protein Antibodies Arise During Affinity Maturation of Germline-Encoded Antibodies to Carbamylated Proteins in Rheumatoid Arthritis
- Abstract Number: 0098
Anti-HSP90α as a Protective Natural Antibody Against Secondary Antiphospholipid Syndrome in Systemic Lupus Erythematosus
- Abstract Number: 2305
Anti-Ku Positivity in Primary Sjögren’s Disease Is Associated with a More Systemic Active Disease
- Abstract Number: 0338
Anti-MDA5 Antibody-positive Dermatomyositis Associated Interstitial Lung Disease – Survival Benefit of Treatment with Rituximab, Janus Kinase Inhibitor and Glucocorticoid Combination in a Prospective Cohort
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 181
- Next Page »